Hybrid Medical It is a New Day in Breast Cancer Treatment

Hybrid Medical Analytics it is a New Day in Breast Cancer.

The question is which targeted Breast Cancer Therapy is best for a individual Patients. Is Genomics the Anwser ?

Hybrid Medical Analytics CIO Reports when Researchers sequence the genomes of 14 triple-negative breast cancer patients with tumors that have progressed despite multiple therapies Breast Cancer patients have a new way to extend life.

The triple-negative tumors make up nearly 20% of breast cancers and do not respond to standard targeted therapies.

In Hybrid Medical Partners Clinical Trials Scientist study both Tumors and Healthy Tissue Sequenced. Then Scientists collaborate on the development using informatics from Hybrid Medical Analytics software that is used with whole genome sequencing. What Scientist in clinical trials Attempt to show how one new drug can be safe and effective for hundreds of people.

Hybrid Medical eLab Notebooks Genomics uses sequencing data from one individual to evaluate which anticancer drugs could be most effective based on normal and tumor genetic makeup

Our Clinical Trial Partners are showing a 80% effective rate using the Genomics Science approach

Hybrid Medical Analytics Area of Research

* Breast cancer
* Endocrine system cancer
* Gastrointestinal cancer
* Genitourinary cancer
* Gynaecological cancer
* Haematological cancer
* Head and neck cancer
* Neurooncology
* Paediatric oncology
* Thoracic oncology
* Sarcoma
* Skin cancer
* Epidemiology, cancer prevention, and cancer control
* Supportive care
* Imaging
* Health-care systems

15 % of Black Women to 7 % of White Women are diagnosed with Breast Cancer. Can Genomics be the Tool to low the rate in which black women are dia

15 percent of Black Women to 7 percent of White Women are diagnosed with Breast Cancer. Can Genomics be the tool to low the rate in which black women are diagnosed with Breast Cancer and extend their lives.

We know that there are 194,280 Americans will be diagnosed with breast cancer this year and 40,610 will die from the disease. 15 percent Black to 7 percent White.

Some guidelines recommend that Cancer stem cells is the fuel that grow Breast Cancer tumor's. Others guidelines recommend that bone mineral density is the fuel that grows tumors.
Chemotherapies do not work against these cells, which is why cancer recurs and spreads. Hybrid Medical Analytics believe that eliminating the cancer stem cells is key to controlling cancer.

21 percent of black women and 15 percent of white women do not receive the minimum expected treatment. Black Women have shorter survival and higher mortality observed for black women
compared to white women.The correlation of lower social class and the lack of Health Care equals less screening, and later stage diagnosis.

Can Genomics be the answer for Black women ? Genomics Science looks at groups of genes and how active they are. This activity can influence how a cancer is likely to grow and respond to treatment.
Hybrid Medical Analytics Genomics Science looks at 21 genes in a patient’s breast cancer tumor in trials to understand how these genes interact and influence the tumor’s behavior.

Genomics is personalized treatment that will reduce the rate of cancer for Black Women.

Tamoxifen and Raloxifene works the same for Balck and White Women, but to many Black Women say the treatment can be toxic. Black Women state that too much toxicity leads to not taking the treatment.

Hybrid Medical Analytics Area of Research

* Breast cancer
* Endocrine system cancer
* Gastrointestinal cancer
* Genitourinary cancer
* Gynaecological cancer
* Haematological cancer
* Head and neck cancer
* Neurooncology
* Paediatric oncology
* Thoracic oncology
* Sarcoma
* Skin cancer
* Epidemiology, cancer prevention, and cancer control
* Supportive care
* Imaging
* Health-care systems

Hybrid Medical Analytics CIO Reports Our Sybase Geonomics Glioblastoma Data Mining Shows that the PTPRD Gene shows to be Promising.

Biotech: Hybrid Medical Analytics CIO Reports that our Sybase Geonomics Glioblastoma Data Mining Shows that the PTPRD Gene shows to be Promising.

Three of every 100,000 Americans have been diagnosed with glioblastoma multiforme ....malignant brain tumors. Most patients with glioblastoma die of the disease within approximately 14 months of diagnosis.

Glioblastoma is not a single disease that appears to be four distinct molecular subtypes Cancer Cell,Investigation of targeted Therapies may improve the near uniformly fatal prognosis of this cancer.

The ability to differentiate Glioblastoma Tumors based on their altered genetic code.Using a cancer's genome to unravel the molecular changes. Comprehensive and coordinated effort to accelerate understanding of how molecular can help extend life
based on cancer through the application of genome analysis technologies and large-scale genome sequencing.

Hybrid Medical analysis Geonomics shows the PTPRD mutations in both the blood and in tumors of a patient with Glioblastoma cancers, can be responsible for an inherited susceptibale to Brain Cancer.

Hybrid Medical Analytics Area of Research

* Breast cancer
* Endocrine system cancer
* Gastrointestinal cancer
* Genitourinary cancer
* Gynaecological cancer
* Haematological cancer
* Head and neck cancer
* Neurooncology
* Paediatric oncology
* Thoracic oncology
* Sarcoma
* Skin cancer
* Epidemiology, cancer prevention, and cancer control
* Supportive care
* Imaging
* Health-care systems

Diagnosed with Breast Cancer should your treatment be Tamoxifen or Chemotherapy ? A Geonomics test will answer this question

Diagnosed with Breast Cancer should your treatment be Tamoxifen or Chemotherapy ? A Geonomics test will answer this question

Hybrid Medical Analytics asked genetics or geonomics. Genetics is the study of how inherited Cancer traits that are passed from one generation to the next through your genes. New genetics traits appear by way of genetic changes. These traits may be characteristics like eye or hair color.

A predisposition to certain types of diseases can be passed through your genes, such as the BRCA1 and BRCA2 genes which normally help control cell growth.

A person who inherits an altered version of the BRCA1 and-or BRCA2 gene(s) has a higher risk of developing breast and ovarian cancer. If someone in your Family has Breast Cancer you can get a genetic tests for BRCA1 and BRCA2.

When a Breast Cancer Patient is Diagnosed as a high-risk Breast Cancer patient they should get a genomic test. A genomic test looks at groups of genes and how active they are. This activity can influence how a cancer is likely to grow and respond to treatment.

Hybrid Medical Analytics uses our Electronic Science Notebooks to identify 21 genes in a patient’s breast tumor to understand how these genes interact and influence the tumor’s behavior, contribute to the development of a cancer cell and its progression from a localized cancer to one that grows uncontrolled and metastasizes.

Oncologist can you this information to better understand whether breast cancer patients are likely to benefit from treatments such as tamoxifen or certain chemotherapy regimens, or whether those patients are likely to experience a recurrence of their cancer.

Hybrid Medical Analytics Area of Research

* Breast cancer
* Endocrine system cancer
* Gastrointestinal cancer
* Genitourinary cancer
* Gynaecological cancer
* Haematological cancer
* Head and neck cancer
* Neurooncology
* Paediatric oncology
* Thoracic oncology
* Sarcoma
* Skin cancer
* Epidemiology, cancer prevention, and cancer control
* Supportive care
* Imaging
* Health-care systems

What would you do if you had a Baby and found a Tumor on his chest and had no health Insurance

What would you do if you had a Baby and found a Tumor on his chest and had no health Insurance ? Your Baby would most likely have Neuroblastoma Cancer. Once Diagnosed with
Neuroblastoma Cancer the good news is that experimental treatment significantly improved progression-free survival in patients with neuroblastoma at high risk for recurrence.

Neuroblastoma Cancer develop from cells of the sympathetic nervous system, A Clinical trial that is showing promise is a study that treatment of high-risk neuroblastoma of the ch14.18 monoclonal antibody. 90% of kids in this study live to 5 years.
The Goal here is to stimulate glycolipid (GD2) force the immune system responded.

The trial used standard therapy, which includes intensive chemotherapy, surgery, and a stem cell transplant, followed by radiation therapy.

Hybrid Medical Analytics is a leader in stem cell R&D with our Lab eNotebook.

Hybrid Medical Analytics Area of Research

* Breast cancer
* Endocrine system cancer
* Gastrointestinal cancer
* Genitourinary cancer
* Gynaecological cancer
* Haematological cancer
* Head and neck cancer
* Neurooncology
* Paediatric oncology
* Thoracic oncology
* Sarcoma
* Skin cancer
* Epidemiology, cancer prevention, and cancer control
* Supportive care
* Imaging
* Health-care systems

Hong Kong: Hybrid Medical Analytics Algorithm - Drugs Treatments that kill Breast Cancer Stem Cells has shown Promise

Hong Kong: Hybrid Medical Analytics Algorithm - Drugs Treatments
that kill Breast Cancer Stem Cells has shown Promise

Hybrid Medical Research Base Protocol stem cell transplantation for the treatment of advanced and early-stage breast cancer is shown promise when adding Collaborative Technology Mythologies to the process. The treatment of high-dose chemotherapy with transplantation as apposed to treatment with more standard doses of chemotherapy.

When pointing Hybrid Medical Algorithm to breast cancer patients with four or more lymph nodes positive for cancer and who are at high risk of recurrence of Breast Cancer have received the best results. These Women are treated with high-dose chemotherapy with granulocyte colony stimulating factor (G-CSF) to stimulate white blood cell production.

Our Oncologist Clients are driven by the fact that more than 75 percent of the women who had heard of high-dose chemotherapy with transplant said they would very likely consider this form of treatment if faced with a decision about breast cancer treatment.

Hybrid Medical CIO Reports that Breast Cancer Stem Cells Treatments are here to stay.

Hybrid Medical Analytics Area of Research

* Breast cancer
* Endocrine system cancer
* Gastrointestinal cancer
* Genitourinary cancer
* Gynaecological cancer
* Haematological cancer
* Head and neck cancer
* Neurooncology
* Paediatric oncology
* Thoracic oncology
* Sarcoma
* Skin cancer
* Epidemiology, cancer prevention, and cancer control
* Supportive care
* Imaging
* Health-care systems

Hereditary Cancer Syndromes BRCA1 shows Concerns about Whole Body Scans in Breast Cancer Patients Kids

Hybrid Medical Analytics CIO Reports that Hereditary Cancer Syndromes BRCA1 shows Concerns about Whole Body Scans in Breast Cancer Patients Kids.

The names BRCA1 and BRCA2 stand for breast cancer susceptibility
gene 1 and breast cancer susceptibility gene 2.

Five percent of the Uninsured Americans is Radiosensitive. One percent of the five percent carry the BRCA1 and BRCA2 breast cancer genes.

Scanning technology reveals detailed images of breasts, genitalia,
surgical implantsa. In less-developed nation might adopt backscatter scanning technology and fail to keep their scanners calibrated.

Test for BRCA1 and BRCA2 mutations look for
changes in BRCA1 and BRCA2 DNA and changes
in the proteins produced by these genes.
Hybrid Medical Analytics Recommend that if you have family member with a history of breast and/or ovarian cancer,ask your Physician to test for BRAC1 and BrcA2.

Hybrid Medical Analytics Area of Research

* Breast cancer
* Endocrine system cancer
* Gastrointestinal cancer
* Genitourinary cancer
* Gynaecological cancer
* Haematological cancer
* Head and neck cancer
* Neurooncology
* Paediatric oncology
* Thoracic oncology
* Sarcoma
* Skin cancer
* Epidemiology, cancer prevention, and cancer control
* Supportive care
* Imaging
* Health-care systems